{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T04:32:00Z","timestamp":1789792320279,"version":"4.0.1"},"reference-count":26,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100012659","name":"Foundation for Innovative Research Groups of the National Natural Science Foundation of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100012659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82230114"],"award-info":[{"award-number":["82230114"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82171224"],"award-info":[{"award-number":["82171224"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Medicinal Chemistry"],"published-print":{"date-parts":[[2025,7]]},"DOI":"10.1016\/j.ejmech.2025.117597","type":"journal-article","created":{"date-parts":[[2025,4,7]],"date-time":"2025-04-07T20:49:36Z","timestamp":1744058976000},"page":"117597","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"special_numbering":"C","title":["Proof of concept study for developing 1-thienyl-\u03b2-carboline derivatives as IDO1 and TDO dual inhibitors to treat Parkinson's disease complicating depression"],"prefix":"10.1016","volume":"291","author":[{"given":"Xuan","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengxiao","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qingyuan","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhenquan","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junjie","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pingping","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongzhen","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lili","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xun","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lili","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katsuhisa","family":"Horimoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fei","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feng","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dongyin","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejmech.2025.117597_bib1","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1038\/s41572-021-00280-3","article-title":"Parkinson disease-associated cognitive impairment","volume":"7","author":"Aarsland","year":"2021","journal-title":"Nat. Rev. Dis. Primers"},{"key":"10.1016\/j.ejmech.2025.117597_bib2","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/S0140-6736(23)01478-2","article-title":"The pathogenesis of Parkinson's disease","volume":"403","author":"Morris","year":"2024","journal-title":"Lancet"},{"key":"10.1016\/j.ejmech.2025.117597_bib3","doi-asserted-by":"crossref","DOI":"10.1016\/j.arr.2022.101840","article-title":"Neurobiology of depression in Parkinson's disease: insights into epidemiology, molecular mechanisms and treatment strategies","volume":"85","author":"Ahmad","year":"2023","journal-title":"Ageing Res. Rev."},{"key":"10.1016\/j.ejmech.2025.117597_bib4","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/S1474-4422(06)70373-8","article-title":"Non-motor symptoms of Parkinson's disease: diagnosis and management","volume":"5","author":"Chaudhuri","year":"2006","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.ejmech.2025.117597_bib5","doi-asserted-by":"crossref","DOI":"10.1016\/j.neubiorev.2022.104749","article-title":"Prevalence and clinical aspects of depression in Parkinson's disease: a systematic review and meta-analysis of 129 studies","volume":"141","author":"Cong","year":"2022","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.ejmech.2025.117597_bib6","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.3233\/JPD-223207","article-title":"Frequency of depressive disorders in Parkinson's disease: a systematic review and meta-analysis","volume":"12","author":"Chendo","year":"2022","journal-title":"J. Parkinsons Dis."},{"key":"10.1016\/j.ejmech.2025.117597_bib7","doi-asserted-by":"crossref","first-page":"312","DOI":"10.3934\/Neuroscience.2024020","article-title":"Novel perspective of therapeutic modules to overcome motor and nonmotor symptoms in Parkinson's disease","volume":"11","author":"Kumar","year":"2024","journal-title":"AIMS. Neurosci."},{"key":"10.1016\/j.ejmech.2025.117597_bib8","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1016\/j.cmet.2023.06.004","article-title":"Tryptophan metabolism in health and disease","volume":"35","author":"Xue","year":"2023","journal-title":"Cell Metab."},{"key":"10.1016\/j.ejmech.2025.117597_bib9","doi-asserted-by":"crossref","first-page":"858","DOI":"10.14336\/AD.2022.0916","article-title":"Tryptophan metabolism in central nervous system diseases: pathophysiology and potential therapeutic strategies","volume":"14","author":"Huang","year":"2023","journal-title":"Aging. Dis."},{"key":"10.1016\/j.ejmech.2025.117597_bib10","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.3389\/fpsyg.2017.01561","article-title":"The relationships among tryptophan, kynurenine, indoleamine 2,3-dioxygenase, depression, and neuropsychological performance","volume":"8","author":"Hestad","year":"2017","journal-title":"Front. Psychol."},{"key":"10.1016\/j.ejmech.2025.117597_bib11","doi-asserted-by":"crossref","first-page":"2028","DOI":"10.1002\/mds.28202","article-title":"Tryptophan metabolites are associated with symptoms and nigral pathology in Parkinson's disease","volume":"35","author":"Heilman","year":"2020","journal-title":"Mov. Disord."},{"key":"10.1016\/j.ejmech.2025.117597_bib12","doi-asserted-by":"crossref","first-page":"1702","DOI":"10.1212\/WNL.42.9.1702","article-title":"Kynurenine pathway abnormalities in Parkinson's disease","volume":"42","author":"Ogawa","year":"1992","journal-title":"Neurology"},{"key":"10.1016\/j.ejmech.2025.117597_bib13","doi-asserted-by":"crossref","DOI":"10.3389\/fmolb.2022.897929","article-title":"Systemic tryptophan homeostasis","volume":"9","author":"Klaessens","year":"2022","journal-title":"Front. Mol. Biosci."},{"key":"10.1016\/j.ejmech.2025.117597_bib14","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1038\/s41573-019-0016-5","article-title":"Tryptophan metabolism as a common therapeutic target in cancer, neurodegeneration and beyond","volume":"18","author":"Platten","year":"2019","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.ejmech.2025.117597_bib15","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1038\/sj.mp.4002148","article-title":"Lipopolysaccharide-induced depressive-like behavior is mediated by indoleamine 2,3-dioxygenase activation in mice","volume":"14","author":"O'Connor","year":"2009","journal-title":"Mol. Psychiatr."},{"key":"10.1016\/j.ejmech.2025.117597_bib16","doi-asserted-by":"crossref","DOI":"10.1016\/j.jep.2023.116714","article-title":"Identification of paeoniflorin from Paeonia lactiflora pall, as an inhibitor of tryptophan 2,3-dioxygenase and assessment of its pharmacological effects on depressive mice","volume":"317","author":"Liang","year":"2023","journal-title":"J. Ethnopharmacol."},{"key":"10.1016\/j.ejmech.2025.117597_bib17","doi-asserted-by":"crossref","first-page":"11214","DOI":"10.1021\/acs.jmedchem.2c00677","article-title":"Discovery of 1-(hetero)aryl-\u03b2-carboline derivatives as Ido1\/TDO dual inhibitors with antidepressant activity","volume":"65","author":"Zhang","year":"2022","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.117597_bib18","doi-asserted-by":"crossref","first-page":"8303","DOI":"10.1021\/acs.jmedchem.1c00303","article-title":"X-ray structure-guided discovery of a potent, orally bioavailable, dual human indoleamine\/tryptophan 2,3-dioxygenase (hIDO\/hTDO) inhibitor that shows activity in a mouse model of Parkinson's disease","volume":"64","author":"Ning","year":"2021","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.117597_bib19","doi-asserted-by":"crossref","DOI":"10.1126\/science.abm6131","article-title":"Restoring hippocampal glucose metabolism rescues cognition across Alzheimer's disease pathologies","volume":"385","author":"Minhas","year":"2024","journal-title":"Science"},{"key":"10.1016\/j.ejmech.2025.117597_bib20","doi-asserted-by":"crossref","first-page":"1925","DOI":"10.1111\/bph.13754","article-title":"Zebrafish models in neuropsychopharmacology and CNS drug discovery","volume":"174","author":"Khan","year":"2017","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.ejmech.2025.117597_bib21","doi-asserted-by":"crossref","DOI":"10.3389\/fnmol.2022.940484","article-title":"Zebrafish as a model organism for neurodegenerative disease","volume":"15","author":"Chia","year":"2022","journal-title":"Front. Mol. Neurosci."},{"key":"10.1016\/j.ejmech.2025.117597_bib22","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2022.835827","article-title":"A critical review of zebrafish models of Parkinson's disease","volume":"13","author":"Doyle","year":"2022","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.ejmech.2025.117597_bib23","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1186\/s12974-021-02196-x","article-title":"Intravenous administration of LPS activates the kynurenine pathway in healthy male human subjects: a prospective placebo-controlled cross-over trial","volume":"18","author":"Millischer","year":"2021","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.ejmech.2025.117597_bib24","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1021\/acschemneuro.9b00669","article-title":"Low-dose ketamine improves LPS-induced depression-like behavior in rats by activating cholinergic anti-inflammatory pathways","volume":"11","author":"Zhao","year":"2020","journal-title":"ACS Chem. Neurosci."},{"key":"10.1016\/j.ejmech.2025.117597_bib25","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2022.109092","article-title":"Targeting PERK mediated endoplasmic reticulum stress attenuates neuroinflammation and alleviates lipopolysaccharide-induced depressive-like behavior in male mice","volume":"111","author":"Xu","year":"2022","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.ejmech.2025.117597_bib26","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.1016\/j.addr.2012.09.042","article-title":"Intestinal drug transporters: an overview","volume":"65","author":"Estudante","year":"2013","journal-title":"Adv. Drug Deliv. Rev."}],"container-title":["European Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523425003629?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523425003629?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,6]],"date-time":"2026-05-06T04:43:18Z","timestamp":1778042598000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0223523425003629"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7]]},"references-count":26,"alternative-id":["S0223523425003629"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmech.2025.117597","relation":{},"ISSN":["0223-5234"],"issn-type":[{"value":"0223-5234","type":"print"}],"subject":[],"published":{"date-parts":[[2025,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Proof of concept study for developing 1-thienyl-\u03b2-carboline derivatives as IDO1 and TDO dual inhibitors to treat Parkinson's disease complicating depression","name":"articletitle","label":"Article Title"},{"value":"European Journal of Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejmech.2025.117597","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Masson SAS. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"117597"}}